Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9340582 Bioconjugates of synthetic apelin polypeptides

Patent 9340582 was granted and assigned to Novartis on May, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

93405820

Patent Inventor Names

Philipp Grosche0

Shari Lynn Caplan0

Changgang Lou0

Eric Peters0

Frederic Zecri0

Hongjuan Zhao0

Jun Yuan0

Date of Patent

May 17, 2016

Patent Application Number

143362900

Date Filed

July 21, 2014

Patent Citations Received

‌

US Patent 12077795 Method for biocatalytic protein-oligonucleotide conjugation

Patent Primary Examiner

‌

Karlheinz R. Skowronek

Patent abstract

The invention provides a bioconjugates comprising a synthetic polypeptide of Formula I′ (SEQ ID NO: 1):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9340582 Bioconjugates of synthetic apelin polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API